[Autoimmune lymphoproliferative syndrome(ALPS)].
Department of Pediatrics, Faculty of Medicine, Kanazawa University.
Y
Y
Kasahara
D017209:Apoptosis; D001327:Autoimmune Diseases / Q000145:classification / Q000209:etiology; D053455:Caspase 10; D020169:Caspases / Q000235:genetics / Q000378:metabolism; D053222:Fas Ligand Protein; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000145:classification / Q000209:etiology; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D011379:Prognosis; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology; D019014:fas Receptor / Q000235:genetics / Q000378:metabolism
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D019014:fas Receptor; D053455:Caspase 10; D020169:Caspases; C506438:CASP10 protein, human